Kafka Steven J. 4
4 · Foundation Medicine, Inc. · Filed Feb 9, 2018
Insider Transaction Report
Form 4
Kafka Steven J.
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-02-07$70.13/sh−23,064$1,617,478→ 61,361 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on February 6, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- [F2]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.12 to $70.46, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.